Taken together, these results indicate that the overexpression of LEF1 is positively associated with the expression of ID1, which in turn activates the TGF-β pathway and promotes the tumorigenicity of ESCC. The gene discussed is TGFB1; the disease is esophageal squamous cell carcinoma.